Influence of endocrine multidisciplinary tumor board on patient management and treatment decision making

Am J Surg. 2022 Jan;223(1):76-80. doi: 10.1016/j.amjsurg.2021.07.013. Epub 2021 Jul 18.

Abstract

Background: Multidisciplinary Tumor Boards (MDT) are used to obtain input regarding cancer management. This study assessed the impact of our institutional Endocrine MDT.

Methods: MDT notes on patients with thyroid cancer treated during 2012-2018 were abstracted retrospectively from the electronic medical record. Management change (MC) was prospectively collected by the MDT coordinator. Biannual evaluations reviewed the impact of the MDT as observed by attendees.

Results: MC was recommended in 47 (15%) of 286 presentations, with additional imaging being the most frequent (43%). Presentation of recurrences were more likely to result in MC (24% vs. 13% initial, p = 0.03). Overall, 98% of attendees found the conference exceeded educational expectations. About 24% reported intending to use a more evidence/guideline-based approach after attending and this trend increased over time (p = 0.002).

Conclusion: MDT presentations led to a higher rate of MC particularly in recurrent TC patients and increased evidenced-based practice for attendees.

Keywords: Evidence-based medicine; Multidisciplinary; Thyroid cancer; Thyroid imaging; Tumor board.

MeSH terms

  • Adolescent
  • Clinical Decision-Making / methods*
  • Endocrinology / standards
  • Evidence-Based Medicine / standards
  • Female
  • Humans
  • Male
  • Medical Oncology / standards
  • Patient Care Team / standards*
  • Practice Guidelines as Topic
  • Retrospective Studies
  • Thyroid Cancer, Papillary / diagnosis
  • Thyroid Cancer, Papillary / therapy*
  • Thyroid Gland / diagnostic imaging
  • Thyroid Neoplasms / diagnosis
  • Thyroid Neoplasms / therapy*
  • Young Adult